|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Dept. of Physiology and Graduate Center for Nutritional Sciences, University of Kentucky, Lexington, KY, USA
2 Center for Cell Signaling, University of Virginia, Charlottesville, VA, USA
* To whom correspondence should be addressed. E-mail: mcgong2{at}uky.edu.
CPI-17 (Protein kinase C potentiated phosphatase inhibitor of 17 KD) mediates some agonist-induced smooth muscle contraction by suppressing the myosin phosphatase in a phosphorylation-dependent manner. Physiological relevant kinase(s) that phosphorylate CPI-17 remains to be identified. Several previous studies have shown that some agonist-induced CPI-17 phosphorylation in smooth muscle tissues was attenuated by the Rho kinase (ROCK) inhibitor Y-27632, suggesting ROCK is involved in agonist-induced CPI-17 phosphorylation. However, Y-27632 has recently been found to inhibit protein kinase C
(PKC
), a well- recognized CPI-17 kinase. Thus, the role of ROCK in agonist-induced CPI-17 phosphorylation remains uncertain. The current study is designed to address this important issue. We selectively activated the RhoA pathway by inducible adenoviral-mediated expression of a constitutively active mutant RhoA (V14RhoA) in primary cultured rabbit aortic smooth muscle cells (VSMCs). V14RhoA caused expression level-dependent CPI-17 phosphorylation at Thr-38 as well as myosin phosphatase phosphorylation at Thr-853. Importantly, we showed that V14RhoA-induced CPI-17 phosphorylation was not affected by PKC inhibitor GF109203x but was abolished by Y-27632, suggesting that ROCK but not PKC was involved. Further, we showed that contractile agonists, thrombin and U46619, induced CPI-17 phosphorylation in VSMCs. Similar to V14RhoA-induced CPI-17 phosphorylation, thrombin-induced CPI-17 phosphorylation was not affected by inhibition of PKC with GF109203x but was blocked by inhibition of RhoA with adenoviral-mediated expression of exoenzyme C3 as well as by Y-27632. Taken together, we provide the first clear evidence indicating that ROCK is responsible for thrombin- and U-46619-induced CPI-17 phosphorylation in primary cultured VSMCs.
This article has been cited by other articles:
![]() |
P. H. Ratz and A. S. Miner Role of Protein Kinase C{zeta} and Calcium Entry in KCl-Induced Vascular Smooth Muscle Calcium Sensitization and Feedback Control of Cellular Calcium Levels J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 399 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Seok, I. Baek, Y.-H. Kim, Y.-S. Jeong, I.-J. Lee, D. H. Shin, Y. H. Hwang, and I. K. Kim Isoflavone Attenuates Vascular Contraction through Inhibition of the RhoA/Rho-Kinase Signaling Pathway J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 991 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Nuno, V. P. Korovkina, S. K. England, and K. G. Lamping RhoA Activation Contributes to Sex Differences in Vascular Contractions Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1934 - 1940. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maeda, Y.-i. Ozaki, S. Sivakumaran, T. Akiyama, H. Urakubo, A. Usami, M. Sato, K. Kaibuchi, and S. Kuroda Ca-independent phospholipase A2-dependent sustained Rho-kinase activation exhibits all-or-none response. Genes Cells, September 1, 2006; 11(9): 1071 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pang, Z. Guo, Z. Xie, W. Su, and M. C. Gong Divergent kinase signaling mediates agonist-induced phosphorylation of phosphatase inhibitory proteins PHI-1 and CPI-17 in vascular smooth muscle cells Am J Physiol Cell Physiol, March 1, 2006; 290(3): C892 - C899. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xie, W. Su, Z. Guo, H. Pang, S. R. Post, and M. C. Gong Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells Cardiovasc Res, February 1, 2006; 69(2): 491 - 501. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |